NEWARK, Calif. (AP) — NEWARK, Calif. (AP) — Protagonist Therapeutics Inc. (PTGX) on Thursday reported a loss of $39.3 million in its third quarter.
On a per-share basis, the Newark, California-based company said it had a loss of 62 cents.
The results did not meet Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 59 cents per share.
The biopharmaceutical company posted revenue of $4.7 million in the period, also missing Street forecasts. Three analysts surveyed by Zacks expected $10 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PTGX at https://www.zacks.com/ap/PTGX
/Amazon%20-%20Image%20by%20bluestork%20via%20Shutterstock.jpg)
/Intel%20Corp_%20logo%20on%20mobile%20phone-by%20Piotr%20Swat%20via%20Shutterstock.jpg)
